BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families
First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
Triple‑negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia
BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management